Tafamidis Meglumine
| CAS No. | 951395-08-7 |
|---|---|
| MDL No. | N/A |
| MF | C21H24Cl2N2O8 |
| MW | 503.30 |
| InChI Key | DQJDBUPLRMRBAB-WZTVWXICSA-N |
| CAS No. | 951395-08-7 |
|---|---|
| MDL No. | N/A |
| MF | C21H24Cl2N2O8 |
| MW | 503.30 |
| InChI Key | DQJDBUPLRMRBAB-WZTVWXICSA-N |
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Tafamidis meglumine is an organoammonium salt formed by combining tafamidis with one molar equivalent of 1-deoxy-1-(methylamino)-D-glucitol. It is used for the treatment of transthyretin-related hereditary amyloidosis and functions as a central nervous system drug. It contains tafamidis(1-).
| CAS No. | 951395-08-7 |
|---|---|
| Product Name | Tafamidis Meglumine |